1. NCCU Academic Hub
  2. Publications
  3. College of Commerce
  4. Theses
  5. Item

Publications-Theses

Article View/Open

Publication Export

Google ScholarTM

NCCU Library

Citation Infomation

Related Publications in TAIR

題名 血友病研究暨防治中心經營模式探討 產學協同開發策略運用
A Business Model of the Hemophilia Care & Research Center - Collaborative Development of Industrial with Government Hospital
作者 周翠雲
Chou, Tsui Yun
貢獻者 郭炳伸
Kuo, Biing Shen
周翠雲
Chou, Tsui Yun
關鍵詞 血友病
血友病治療中心
整體醫療
Hemophiliacs
Hemophilia Treatment Center
Integrated Care
日期 2013
上傳時間 1-Jul-2014 12:09:15 (UTC+8)
摘要 血友病是一種好發於男性的先天性染色體隱性遺傳凝血異常之疾病，病患如何在短時間內處理出血問題，一直是人生主要課題。就此，病患在選擇一個專業綜合性的血友病治療中心（Hemophilia Treatment Center, HTC）時，通常會參考病友團體的建議或HTC的專業醫療團隊就病友所提供的醫療服務，其中以解決病患醫療問題如出血治療，病毒感染追蹤，關節置換及復建療程，消除心理的障礙為主要考量；除此之外，就醫便利性及給予家屬適當衛教成為他們選擇HTC的參數。健保局自2005年開始編列專款作為罕見疾病，愛滋病及血友病治療以來，每年以約15％幅度成長，造就醫療院所為增加院方的利基，因此紛紛增設血友病治療中心照顧血友病患。本研究以北區某家醫學中心與產業界協同合作成立血友病防治暨預防中心為基礎，藉以Porter提出的產業環境五力分析／價值鏈檢視營運模式的關鍵成功因素及利用SWOT分析現行醫療環境發展策略，供該中心作為未來營運的參考。
Hemophilia is an inherited bleeding disorder that causes the blood may not clot properly, most affected boys. Managing with bleeding issue within short time that could be a risk to patients. Those patients, choose a professional comprehensive treatment center (Hemophilia Treatment Center, HTC) usually refer the patient group advises or review the proposal submitted by the HTC’s professional medical service either. Most of them to be concerned bleeding issue, viral infection, arthroplasty and rehabilitation programs, besides eliminate the psychological barriers, convenience for medical service provided and conduct the education programs sharing to families. Bureau of National Insurance allocated the independent budget for rare disease, AIDS and Hemophilia since 2005, about 15% increase annually. To these incentives, some hospitals start to run HTC business recently providing medical service to patient with Hemophilia. The study is aiming HCRC, that is a collaborative development project by both industry and medical center, which locates in north of Taiwan. With Porter’s five force analysis and value chain instrument and SWOT analysis, to validate the key success factors for business model and environment conquer strategy, respectively. That result may offer the new strategy to HCRC for further business development.
參考文獻 1. 疫情報導；台灣地區首例因使用血液製劑引起之艾滋病例報告，中華民國七十六年十月出版, 77 – 78
2. 黃雅琳、孫智麗；台灣經濟研究院生物科技產業研究中心；台灣醫療產業結構與發展趨勢，2003, 1-10
3. Baker, J.R. Iske, B.R, Drake,J. H; US Hemophilia Treatment Center population trends 1990–2010: patient diagnoses, demographics, health services utilization. Haemophilia (2013) 19, 21–26
4. Tu TC, Liou WS, Chou TY, Lin TK, Lee CF, Chen JD, Cham TM, Chung MI. Prevalence, incidence, and factor concentrate usage trends of hemophiliacs in Taiwan . Yonsei Med J. 2013 Jan 1;54(1):71-80.
5. Porter, M.E, Competitive Strategy: Techniques for analysis industries and competitor. New York: Free Pree, 1980
6. 中央研究院報告.,醫療保健政策建議書No. 003, 2009
7. Liou WS, Tu TC, Cheng SN, Chou TY, Lee CF, Lin TK, Chung MI, Cham TM. Secondary prophylaxis treatment versus on-demand treatment for patients with severe haemophilia A: comparisons of cost and outcomes in Taiwan. Haemophilia 2011: 17: 45-54.
8. PL 9463: The Pulbic Health Service Act establishing the hemophilia diagnostic & treatment center program. No 1131 of Public Law 9463 Washington DC: Government Printing Office, 1975
9. Eme’rito-Carlos., Rodrignez-Mercha’m., Valentino, Leomard A., Current & Future issues in Hemophilia Care., Wiley-blackwell., 2011
10. 陳銘樹(2012)．醫療產業策略管理., Healthcare Industry Strategy Management. 華杏出版機構., ISBN 978-986-194-234-6
11. 李明軒，秋如美譯(2010), 競爭優勢／麥克．波特(Michael E. Porter),天下遠見., 譯自：Competitive advantage : creating and sustaining superior performance.
12. Channom, D.K..SWOT analysis entry in handbook of strategic management. New York: M. Dekker. 1989
13. Franchini, M., Tagliaferri, A., Mannucio, P. The management of hemophilia in elderly patients. Clin Interv Aging. 2007 September; 2(3): 361–368
14. Kolter, P., Keller, K., Marketing Management: Application, Planning, Implementation and Control，1967
15. Keller, KL., Building Customer-Based brand equity: A blueprint for creating strong brand. Marketing Science Institute. Report summary, 2001. 01-107
描述 碩士
國立政治大學
經營管理碩士學程(EMBA)
101932023
102
資料來源 http://thesis.lib.nccu.edu.tw/record/#G0101932023
資料類型 thesis
dc.contributor.advisor 郭炳伸zh_TW
dc.contributor.advisor Kuo, Biing Shenen_US
dc.contributor.author (Authors) 周翠雲zh_TW
dc.contributor.author (Authors) Chou, Tsui Yunen_US
dc.creator (作者) 周翠雲zh_TW
dc.creator (作者) Chou, Tsui Yunen_US
dc.date (日期) 2013en_US
dc.date.accessioned 1-Jul-2014 12:09:15 (UTC+8)-
dc.date.available 1-Jul-2014 12:09:15 (UTC+8)-
dc.date.issued (上傳時間) 1-Jul-2014 12:09:15 (UTC+8)-
dc.identifier (Other Identifiers) G0101932023en_US
dc.identifier.uri (URI) http://nccur.lib.nccu.edu.tw/handle/140.119/67120-
dc.description (描述) 碩士zh_TW
dc.description (描述) 國立政治大學zh_TW
dc.description (描述) 經營管理碩士學程(EMBA)zh_TW
dc.description (描述) 101932023zh_TW
dc.description (描述) 102zh_TW
dc.description.abstract (摘要) 血友病是一種好發於男性的先天性染色體隱性遺傳凝血異常之疾病，病患如何在短時間內處理出血問題，一直是人生主要課題。就此，病患在選擇一個專業綜合性的血友病治療中心（Hemophilia Treatment Center, HTC）時，通常會參考病友團體的建議或HTC的專業醫療團隊就病友所提供的醫療服務，其中以解決病患醫療問題如出血治療，病毒感染追蹤，關節置換及復建療程，消除心理的障礙為主要考量；除此之外，就醫便利性及給予家屬適當衛教成為他們選擇HTC的參數。健保局自2005年開始編列專款作為罕見疾病，愛滋病及血友病治療以來，每年以約15％幅度成長，造就醫療院所為增加院方的利基，因此紛紛增設血友病治療中心照顧血友病患。本研究以北區某家醫學中心與產業界協同合作成立血友病防治暨預防中心為基礎，藉以Porter提出的產業環境五力分析／價值鏈檢視營運模式的關鍵成功因素及利用SWOT分析現行醫療環境發展策略，供該中心作為未來營運的參考。zh_TW
dc.description.abstract (摘要) Hemophilia is an inherited bleeding disorder that causes the blood may not clot properly, most affected boys. Managing with bleeding issue within short time that could be a risk to patients. Those patients, choose a professional comprehensive treatment center (Hemophilia Treatment Center, HTC) usually refer the patient group advises or review the proposal submitted by the HTC’s professional medical service either. Most of them to be concerned bleeding issue, viral infection, arthroplasty and rehabilitation programs, besides eliminate the psychological barriers, convenience for medical service provided and conduct the education programs sharing to families. Bureau of National Insurance allocated the independent budget for rare disease, AIDS and Hemophilia since 2005, about 15% increase annually. To these incentives, some hospitals start to run HTC business recently providing medical service to patient with Hemophilia. The study is aiming HCRC, that is a collaborative development project by both industry and medical center, which locates in north of Taiwan. With Porter’s five force analysis and value chain instrument and SWOT analysis, to validate the key success factors for business model and environment conquer strategy, respectively. That result may offer the new strategy to HCRC for further business development.en_US
dc.description.tableofcontents 第一章 緒論 1
第一節 研究背景與動機 1
第二節 研究目的與架構 3
第二章 疾病認識及國外治療沿革探討 5
第一節 血友病疾病簡介 5
第二節 血友病的治療與風險 7
第三節 世界血友病組織(WORLD FEDERATION OF HEMOPHILIA) 9
第四節 血友病治療中心的沿革 10
第五節 台灣血友病醫療 11
第三章 台灣醫療體系與健保改革 15
第一節 台灣醫療體系與健保改革 15
第二節 台灣血友病醫療產業分析 18
第三節 血友病產業五力分析 20
第四章 個案研究 25
第一節 個案簡介 25
第二節 血友病研究暨預防中心簡介 26
第三節 投資策略與進入模式 29
第四節 市場進入模式的戰略 32
第五節 營運策略分析 33
第五章 經營管理策略分析 37
第一節 競爭優勢與價值鏈分析 37
第二節 HCRC 經營成效 （2003 – 2009） 41
第三節 關鍵成功因素分析 45
第四節 經營管理實務探討 46
第六章 討論與建議 50
第一節 討論 50
第二節 建議 53
參考文獻 55
附件 甲		zh_TW
dc.format.extent 4608183 bytes-
dc.format.mimetype application/pdf-
dc.language.iso en_US-
dc.source.uri (資料來源) http://thesis.lib.nccu.edu.tw/record/#G0101932023en_US
dc.subject (關鍵詞) 血友病zh_TW
dc.subject (關鍵詞) 血友病治療中心zh_TW
dc.subject (關鍵詞) 整體醫療zh_TW
dc.subject (關鍵詞) Hemophiliacsen_US
dc.subject (關鍵詞) Hemophilia Treatment Centeren_US
dc.subject (關鍵詞) Integrated Careen_US
dc.title (題名) 血友病研究暨防治中心經營模式探討 產學協同開發策略運用zh_TW
dc.title (題名) A Business Model of the Hemophilia Care & Research Center - Collaborative Development of Industrial with Government Hospitalen_US
dc.type (資料類型) thesisen
dc.relation.reference (參考文獻) 1. 疫情報導；台灣地區首例因使用血液製劑引起之艾滋病例報告，中華民國七十六年十月出版, 77 – 78
2. 黃雅琳、孫智麗；台灣經濟研究院生物科技產業研究中心；台灣醫療產業結構與發展趨勢，2003, 1-10
3. Baker, J.R. Iske, B.R, Drake,J. H; US Hemophilia Treatment Center population trends 1990–2010: patient diagnoses, demographics, health services utilization. Haemophilia (2013) 19, 21–26
4. Tu TC, Liou WS, Chou TY, Lin TK, Lee CF, Chen JD, Cham TM, Chung MI. Prevalence, incidence, and factor concentrate usage trends of hemophiliacs in Taiwan . Yonsei Med J. 2013 Jan 1;54(1):71-80.
5. Porter, M.E, Competitive Strategy: Techniques for analysis industries and competitor. New York: Free Pree, 1980
6. 中央研究院報告.,醫療保健政策建議書No. 003, 2009
7. Liou WS, Tu TC, Cheng SN, Chou TY, Lee CF, Lin TK, Chung MI, Cham TM. Secondary prophylaxis treatment versus on-demand treatment for patients with severe haemophilia A: comparisons of cost and outcomes in Taiwan. Haemophilia 2011: 17: 45-54.
8. PL 9463: The Pulbic Health Service Act establishing the hemophilia diagnostic & treatment center program. No 1131 of Public Law 9463 Washington DC: Government Printing Office, 1975
9. Eme’rito-Carlos., Rodrignez-Mercha’m., Valentino, Leomard A., Current & Future issues in Hemophilia Care., Wiley-blackwell., 2011
10. 陳銘樹(2012)．醫療產業策略管理., Healthcare Industry Strategy Management. 華杏出版機構., ISBN 978-986-194-234-6
11. 李明軒，秋如美譯(2010), 競爭優勢／麥克．波特(Michael E. Porter),天下遠見., 譯自：Competitive advantage : creating and sustaining superior performance.
12. Channom, D.K..SWOT analysis entry in handbook of strategic management. New York: M. Dekker. 1989
13. Franchini, M., Tagliaferri, A., Mannucio, P. The management of hemophilia in elderly patients. Clin Interv Aging. 2007 September; 2(3): 361–368
14. Kolter, P., Keller, K., Marketing Management: Application, Planning, Implementation and Control，1967
15. Keller, KL., Building Customer-Based brand equity: A blueprint for creating strong brand. Marketing Science Institute. Report summary, 2001. 01-107		zh_TW